argenx's stock fell sharply after the company stopped its Phase 3 trial for Sjögren's disease using efgartigimod subcutaneous (VYVGART HYTRULO). Despite this setback, the VYVGART franchise continues to generate strong cash flow and supports ongoing pipeline development. The stock trades at a discount compared to peers like Vertex, maintaining a 'Buy' rating based on growth potential. Risks include commercial underperformance, trial failures, competition, regulatory delays, and capital allocation errors.
The story on argenx and its Sjögren's disease trial setback is presented alongside Pluang's health sector snapshot as of Oct 09, 2026 19:51 WIB. Of 128 health-sector US stocks priced on Pluang, 73 rose and 45 fell. Among notable movers, Recursion Pharmaceuticals Inc (RXRX) rose 1.52% to USD 4.01 with a typical hold time of 22 days and a strong 92% sell order activity, while AbCellera Biologics Inc (ABCL) increased 1.41% to USD 12.19 with 90% buy order activity and a 41-day hold time. Crispr Therapeutics AG (CRSP) also gained 1.33% to USD 51.11 but saw 77% sell order activity and a longer 77-day hold time.
ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...
The Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 2026 merger. The suit alleges that Compass and its executives misrepresented their efforts to secu...
MannKind presented new clinical data at HFSA 2026 showing that Furoscix ReadyFlow, an autoinjector delivering subcutaneous furosemide, provides diuretic effects comparable to IV administration for treating edema in heart failure and chronic kidney di...
A securities class action lawsuit was filed against Millrose Properties, Inc. for allegedly misleading investors by not disclosing that it would lease $200 million worth of properties purchased from Lennar at a loss. The lawsuit claims Millrose misre...
An unidentified trader transferred 1.79 million Uniswap (UNI) tokens, valued at about $13.18 million, from the decentralized lending platform Venus Protocol to the major cryptocurrency exchange Binance. This significant token movement occurred roughl...
